ClinicalTrials.gg

Program

RSS0393

A development code. Also written as “RSS0393 ointment”, “RSS0393 ointment 0.03%” and “RSS0393 Ointment”.

In Jiangsu HengRui Medicine's pipeline, PDE 4. Its studies are mostly in Psoriasis · Dermatitis, Atopic, led by Jiangsu HengRui Medicine.

Furthest: phase 3, since Apr 7, 20264 company-led studies, 3 open or runningNext primary completion: Jan 2027 (phase 3)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Jiangsu HengRui Medicine43 open or runningphase 3since Apr 7, 2026Mar 24, 2025Jan 2027phase 3 · NCT07543224
  • Named in Jiangsu HengRui Medicine’s own pipeline as RSS0393, phase 3, as of Jul 31, 2026 (source).

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Mar 24, 2025First study: phase 2 study in Psoriatic SubjectsFirst studyNCT06918743 · 147 planned
  2. Jul 29, 2025Phase 2 study in Plaque Psoriasis in ChildrenNCT07102888 · 20 planned · China
  3. Aug 28, 2025Phase 2 study in Atopic Dermatitis of AdultsNCT07158151 · 168 enrolled · China
  4. Apr 7, 2026Phase 3 study in Plaque Psoriasis SubjectsPhase 3 reachedNCT07543224 · 600 planned · China

Ahead

  1. Jan 2027Primary completion: phase 3 study in Plaque Psoriasis SubjectsNCT07543224

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07543224Plaque Psoriasis Subjects · China3Not yet recruitingJan 2027600
NCT07158151Atopic Dermatitis of Adults · China2CompletedApr 10, 2026168
NCT07102888Plaque Psoriasis in Children · China2Not yet recruitingFeb 202620
NCT06918743Psoriatic Subjects2Not yet recruitingMar 2026147

How it is read

Names in the registry

  • “RSS0393 ointment”, 6 entries
  • “RSS0393 ointment 0.03%”, 1 entry
  • “RSS0393 Ointment”, 1 entry

Codes read as this program: RSS0393.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.